Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Graft vs Host Disease × Prednisone × Clear all

Phase

Status

Completed 6 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 16 Burkitt Lymphoma 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Follicular 8 Lymphoma, T-Cell, Peripheral 7 Lymphoma, B-Cell 7 Lymphoma 7 Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Biphenotypic, Acute 3 Prostatic Neoplasms, Castration-Resistant 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm, Residual 1

Interventions

Cyclophosphamide 8 fludarabine 5 Melphalan 3 thymoglobulin 2 ruxolitinib 2 Whole-Body Irradiation 2 Thiotepa 2 Tacrolimus 2 Mycophenolic Acid 2 Biopsy 2 venetoclax 1 vedolizumab 1 fludarabine phosphate 1 belumosudil 1 Tomography, Optical Coherence 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Prednisone 1 Methotrexate 1 Mesna 1 Low-Level Light Therapy 1 LDP-02 1 Immunoglobulin G 1 Fecal Microbiota Transplantation 1 Disulfides 1 Clofarabine 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06756061 2025-02-19

FRONTJAK-001

Seoul St. Mary's Hospital

Phase 2 Recruiting

Graft vs Host Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡